Clashes over the Future of Gene Therapy and Crispr at the US’s Biggest Biotech Meeting

For one dizzying, schmooze and booze-filled week every January, thousands of tech execs, VCs, and investment bankers grind their way through a four-day slog of panel sessions, poster presentations, networking meetings, and cocktail-drenched after-hours parties in their industry’s premier orgiastic dealmaking event. And no, we’re not talking about CES. On Monday, the Westin St. Francis […]